Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 192

1.
2.

Estimating the cost-effectiveness of linezolid for the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Taiwan.

Lin PC, Wang BC, Kim R, Magyar A, Lai CC, Yang YW, Huang YC.

J Microbiol Immunol Infect. 2015 Sep 9. pii: S1684-1182(15)00824-5. doi: 10.1016/j.jmii.2015.08.002. [Epub ahead of print]

3.

Economic burden of nosocomial pneumonia in non-intensive care clinics.

Çakir Edis E, Hatipoğlu ON, Yılmam İ, Süt N.

Tuberk Toraks. 2015;63(1):8-12.

4.

Critical analysis of common canister programs: a review of cross-functional considerations and health system economics.

Larson T, Gudavalli R, Prater D, Sutton S.

Curr Med Res Opin. 2015 Apr;31(4):853-60. doi: 10.1185/03007995.2015.1016604. Epub 2015 Mar 19.

PMID:
25686651
5.

Incidence and attributable costs of ventilator-associated pneumonia (VAP) in a tertiary-level intensive care unit (ICU) in northern India.

Mathai AS, Phillips A, Kaur P, Isaac R.

J Infect Public Health. 2015 Mar-Apr;8(2):127-35. doi: 10.1016/j.jiph.2014.07.005. Epub 2014 Oct 28.

PMID:
25444392
6.

Thrombosis: a major contributor to global disease burden.

Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, Ozaki Y, Wendelboe A, Weitz JI; ISTH Steering Committee for World Thrombosis Day.

Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2363-71. doi: 10.1161/ATVBAHA.114.304488. Review.

7.

The cost of hospital care for management of invasive group A streptococcal infections in England.

Hughes GJ, VAN Hoek AJ, Sriskandan S, Lamagni TL.

Epidemiol Infect. 2015 Jun;143(8):1719-30. doi: 10.1017/S0950268814002489. Epub 2014 Sep 29.

PMID:
25262779
8.

[Impact of copper in the reduction of hospital-acquired infections, mortality and antimicrobial costs in the Adult Intensive Care Unit].

Rivero P, Brenner P, Nercelles P.

Rev Chilena Infectol. 2014 Jun;31(3):274-9. doi: 10.4067/S0716-10182014000300004. Spanish.

9.

Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.

Niederman MS, Chastre J, Solem CT, Wan Y, Gao X, Myers DE, Haider S, Li JZ, Stephens JM.

Clin Ther. 2014 Sep 1;36(9):1233-1243.e1. doi: 10.1016/j.clinthera.2014.06.029. Epub 2014 Jul 25.

PMID:
25066668
10.

Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

Patel DA, Shorr AF, Chastre J, Niederman M, Simor A, Stephens JM, Charbonneau C, Gao X, Nathwani D.

Crit Care. 2014 Jul 22;18(4):R157. doi: 10.1186/cc13996.

11.

Funding healthcare-associated infection research: a systematic analysis of UK research investments, 1997-2010.

Head MG, Fitchett JR, Holmes AH, Atun R.

J Hosp Infect. 2014 Jun;87(2):84-91. doi: 10.1016/j.jhin.2014.03.008. Epub 2014 Apr 13.

12.

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.

Chastre J, Blasi F, Masterton RG, Rello J, Torres A, Welte T.

Clin Microbiol Infect. 2014 Apr;20 Suppl 4:19-36. doi: 10.1111/1469-0691.12450. Review.

13.

Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand.

Reechaipichitkul W, Phondongnok S, Bourpoern J, Chaimanee P.

Southeast Asian J Trop Med Public Health. 2013 May;44(3):490-502.

PMID:
24050082
14.

Clinical and economic burden of invasive pneumococcal disease in adults: a multicenter hospital-based study.

Song JY, Choi JY, Lee JS, Bae IG, Kim YK, Sohn JW, Jo YM, Choi WS, Lee J, Park KH, Kim WJ, Cheong HJ.

BMC Infect Dis. 2013 May 4;13:202. doi: 10.1186/1471-2334-13-202.

15.

[Costs associated with nosocomial pneumonia in Universitary Hospital of Santander-Colombia, 2007-2009].

Rodríguez-Burbano L, De La Hoz FP, Leal-Castro AL.

Rev Salud Publica (Bogota). 2013 Mar-Apr;15(2):196-207. Spanish.

16.

Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.

Segarra-Newnham M, Church TJ.

Ann Pharmacother. 2012 Dec;46(12):1678-87. doi: 10.1345/aph.1R370. Epub 2012 Dec 11. Review.

PMID:
23232021
17.

[EzPAP® therapy of postoperative hypoxemia in the recovery room : experiences with the new compact system of end-expiratory positive airway pressure].

Rieg AD, Stoppe C, Rossaint R, Coburn M, Hein M, Schälte G.

Anaesthesist. 2012 Oct;61(10):867-74. doi: 10.1007/s00101-012-2083-4. Epub 2012 Sep 27. German.

PMID:
23011043
18.

Clinical and economic outcomes of a prospective antimicrobial stewardship program.

Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ.

Am J Health Syst Pharm. 2012 Sep 1;69(17):1500-8. doi: 10.2146/ajhp110603.

PMID:
22899745
19.

Obesity and the risk and outcome of infection.

Huttunen R, Syrjänen J.

Int J Obes (Lond). 2013 Mar;37(3):333-40. doi: 10.1038/ijo.2012.62. Epub 2012 May 1. Review.

PMID:
22546772
20.

Prevention of gastrointestinal bleeding due to stress ulceration: a review of current literature.

Pilkington KB, Wagstaff MJ, Greenwood JE.

Anaesth Intensive Care. 2012 Mar;40(2):253-9. Review.

PMID:
22417019
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk